teva

Teva acquires Mexico’s Rimsa for $2.3 billion

October 5, 2015
Research and Development, Sales and Marketing Mexico, Rimsa, Teva, mergers and acquisitions

Strategic Move Enhances Teva’s Presence in Mexico, the Second Largest Market in Latin America and a Major Emerging Market Brings a Portfolio of …

North 51 acquired by Bionical

October 5, 2015
Bionical, North 51, mergers and acquisitions

North 51 Ltd, a Nottingham-based healthcare company has been acquired by Bionical in a multi-million pound deal. The North 51 …

medcity_bojo

Why London is at the heart of life sciences

October 5, 2015
Research and Development NHS

by Eliot ForsterWhatever disease you’re trying to cure, you can bet that somebody in London has it. That probably isn’t …

keytruda

FDA approves Merck’s Keytruda for advanced NSC lung cancer

October 5, 2015
Research and Development, Sales and Marketing BMS, NSCL, keytruda, lung cancer, merck sharp and dohme, opdivo

The US Food and Drug Administration has granted accelerated approval for Merck’s Keytruda (pembrolizumab) to treat patients with advanced (metastatic) …

pfizer_hq_new_york

Pfizer completes $130 million purchase of two GSK vaccines

October 5, 2015
Sales and Marketing GSK, Pfizer, meningitis

Pfizer has announced that it has completed the $130 million acquisition of GlaxoSmithKline’s quadrivalent meningococcal ACWY vaccines Nimenrix and Mencevax. …

david_cameron

David Cameron pledges seven-day GP service by 2020

October 5, 2015
Medical Communications NHS, david cameron

Millions of patients will benefit from ground-breaking plans for seven-day access to both their GPs and hospitals, British Prime Minister …

hilary_clinton

Hillary Clinton takes aim at pharma industry in White House bid

October 5, 2015
Medical Communications, Sales and Marketing turing

Hillary Clinton has taken aim at the pharmaceutical industry with a campaign advert airing in two US states, in which …

sermo

New partnership will speed medical diagnoses through crowdsourcing

October 5, 2015
Medical Communications, Sales and Marketing Global Genes, Sermo

The global social network for physicians, SERMO, is partnering with Global Genes, a leading rare disease patient advocacy organisation, to provide …

Woodley Equipment to Attend Global Site Solutions Summit, Florida, USA

October 2, 2015
Manufacturing and Production, Research and Development woodley equipment

Woodley Equipment will attend the upcoming Global Site Solutions Summit in Florida, USAThe Global Site Solutions Summit is taking place …

abbvie_theresa_may

Home Secretary Theresa May opens Abbvie’s new UK offices

October 2, 2015
Medical Communications AbbVie

AbbVie today opened new UK offices, in a ceremony presided over by Theresa May, Home Secretary and MP for Maidenhead.The company, …

stephen_gough

Professor Stephen Gough joins Novo Nordisk as senior principal clinical scientist

October 2, 2015
Medical Communications, Research and Development Novo Nordisk, Professor Stephen Gough

Novo Nordisk has announced that Professor Stephen Gough, a renowned clinical and research specialist in diabetes, joined the company today …

genzyme_logo

Genzyme opts into Alnylam’s Thrombosis program

October 2, 2015
Medical Communications, Research and Development Alnylam, Genzyme, Sanofi, haemophilia

Sanofi subsidiary Genzyme has elected to opt into Alnylam’s investigational ALN-AT3 hemophilia program for development and potential future commercialisation in …

lyrica

Legal analysis: a summary of the Lyrica pregabalin case and the issue of cross-label use in Europe

October 2, 2015
Medical Communications Lyrica, Pfizer

The Warner Lambert v Actavis pregabalin cases have been before the UK Courts on no less than seven occasions since the beginning of …

generic_doctor

Survey finds GPs have negative views of pharma

October 2, 2015
Medical Communications

A survey by healthcare data and intelligence provider Binley’s has found that more than 40% of GPs have a negative …

sandoz_building

FDA accepts Sandoz submission for Amgen biosimilar

October 2, 2015
Medical Communications, Research and Development Amgen, FDA, Novartis, Sandoz, biosimilars

Sandoz, a Novartis company and a global leader in biosimilars, has announced today that the US Food and Drug Administration …

gene

Berg joins Genomics England project to sequence 100,000 genomes

October 2, 2015
Medical Communications, Research and Development Berg, Genomics england, artificial intelligence

Boston-based biopharmaceutical company Berg has announced it will join an industry collaboration with Genomics England, with the goal of sequencing …

stephen-whitehead-200

CEO Stephen Whitehead leaves ABPI

October 1, 2015
Medical Communications ABPI, Alison Clough, Stephen Whitehead

The ABPI has confirmed that CEO Stephen Whitehead has left the organisation. Speaking on behalf of the Board, John Kearney, …

karen_bernstein

Dr Karen Bernstein joins Ovid and Vitae boards

October 1, 2015
Medical Communications, Sales and Marketing Dr Karen Bernstein, Ovid Therapeutics, Vitae Pharmaceuticals

Ovid Therapeutics has announced the appointment of Karen Bernstein to the company’s Board of Directors. Dr Bernstein says: “I have …

lungs_shiz

Verona Pharma’s respiratory drug proves positive in study

October 1, 2015
Research and Development COPD, verona pharma

Verona Pharma has announced encouraging positive headline data of the third and final part of a randomised, clinical study in …

crp_test

Quick test minimises unnecessary antibiotic prescribing

October 1, 2015
Medical Communications antibiotic resistance

New data presented at this week’s Royal College of General Practitioners (RCGP) Annual Conference reveals that in real-world general practice, …

The Gateway to Local Adoption Series

Latest content